HIMS - Latest News
Hims & Hers Health, Inc. (HIMS), operates in Healthcare / Medical - Care Facilities, trades on NYSE.
Market capitalization stands near $6.24B. Beta to the broader market is 2.43.
The article list below shows the most recent HIMS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent HIMS Headlines
Hims & Hers Health (HIMS) Alert: Securities Fraud Class Action Filed, Investors Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline
newsfilecorp.com - Oct 15, 2026
San Francisco, California--(Newsfile Corp. - October 15, 2026) - Hims & Hers Health, Inc.
Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm
globenewswire.com - Oct 15, 2026
If you purchased or acquired Hims securities between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, contact Bragar Eage
Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Learn About the Securities Class Action Ahead of the November 2, 2026 Deadline
newsfilecorp.com - Oct 15, 2026
New York, New York--(Newsfile Corp. - October 15, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hi
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
globenewswire.com - Oct 15, 2026
NEW ORLEANS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com - Oct 15, 2026
LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors
How News Affects HIMS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track HIMS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked HIMS news questions
- What is the latest HIMS news headline?
- The most recent HIMS headline (Oct 15, 2026) is "Hims & Hers Health (HIMS) Alert: Securities Fraud Class Action Filed, Investors Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the HIMS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What HIMS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual HIMS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.